Consumer group: FDA must ban Avandia because of health risks

10/30/2008 | Washington Post (tiered subscription model), The

Public Citizen, a consumer-advocacy group, called on the FDA to ban GlaxoSmithKline's Avandia because of life-endangering risks, including heart attack and liver failure, linked to the diabetes drug. The agency said it will "carefully review" the petition, which comes after the American Diabetes Association issued revised treatment guidelines that advise against Avandia.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR